Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $415.0000 (1.22%) ($415.0000 - $435.0000) on Wed. Apr. 6, 2011. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.38% (three month average) | RSI | 72 | Latest Price | $415.0000(1.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 5.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 22.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(4%) IWM(3%) XOP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -3.19% in a week (0% probabilities). REMX(-1%) IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.19% (StdDev 6.38%) | Hourly BBV | 0 () | Intraday Trend | -4% | | | |
|
5 Day Moving Average | $420.23(-1.24%) | 10 Day Moving Average | $362.91(14.35%) | 20 Day Moving Average | $331.72(25.11%) | To recent high | -5.6% | To recent low | 62.7% | Market Cap | $8.174b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |